ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.098,09
-0,50%
S&P 500
5.277,51
0,80%
US Dollar vs BRL
5,2463
0,00%
Bitcoin
67.740,62
0,02%
Brent Oil
81,295
0,00%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Chemgenex Pharmaceuticals Ltd (MM) (CXSP)

  7. Chemgenex Pharmaceuticals Ltd (MM) (CXSP) Notícias

CXSP

Chemgenex (CXSP)

Chemgenex Pharmaceuticals Ltd (MM)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:CXSP
DataHoraFonteTítuloCódigoCompanhia
29/06/200910:19Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
01/06/200913:00Business WirePivotal Study Results: ChemGenex’s Omacetaxine May Provide the First Viable Drug Treatment Option for Patients With a Highl...NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
21/05/200908:00Business WireChemGenex’s Omacetaxine to be Showcased in Three Oral Presentations at EHANASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
14/05/200920:30Business WireChemGenex to Present Pivotal Data in T315I Positive CML Patients as Oral Presentation at ASCONASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
09/04/200907:00Business WireChemGenex Completes Capital Raising, Announces Rights IssueNASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
26/03/200907:40Business WireNew Data Suggesting that ChemGenex’s Omacetaxine Can Eradicate Leukemic Stem Cells May Offer a Breakthrough in Treating CMLNASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
30/12/200817:00Edgar (US Regulatory)Annual and Transition Report (foreign private issuer) (20-F)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
16/06/200816:04Edgar (US Regulatory)Chemgenex Pharmaceuticals Ltd - Report of Foreign Issuer (6-K)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
01/04/200809:00Business WireChemGenex Investigators Present Data on Clinical Activity of Omacetaxine in Imatinib-Resistant Chronic Myeloid Leukemia PatientsNASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
27/11/200720:25Edgar (US Regulatory)Chemgenex Pharmaceuticals Ltd - Annual and Transition Report (foreign private issuer) (20-F)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
01/10/200711:41Edgar (US Regulatory)Chemgenex Pharmaceuticals Ltd (Other) (6-K)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
11/06/200717:30Business WireChemGenex Announces Publication Confirming Activity of Ceflatonin(R) in T315I-Positive CMLNASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
02/04/200723:27Business WireChemGenex Announces the Completion of A$21 Million FinancingNASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
05/01/200715:08Business WireChemGenex Pharmaceuticals: Announcement Pursuant To Nasdaq Marketplace Rule 4350(b)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
04/04/200609:00PR Newswire (US)Preclinical Progress Reported at American Association of Cancer Research ConferenceNASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
22/03/200620:26PR Newswire (US)New Preclinical Research Supports Ceflatonin(R) in Treatment of Acute Myeloid Leukemia (AML)NASDAQ:CXSP
20/03/200601:40PR Newswire (US)Orphan Drug Designation Granted by the U.S. FDA for Ceflatonin(R)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
05/03/200620:00PR Newswire (US)Cowen & Co. 26th Annual Health Care Conference to Webcast ChemGenex PresentationNASDAQ:CXSP
17/01/200622:12PR Newswire (US)ChemGenex Granted U.S. Patent on Ceflatonin(R)'s Use for Treatment of Gleevec(R)-Resistant Patients With CML and Ph-Positive ALLNASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
17/01/200611:20PR Newswire (US)New Diabetes Research Contract With Merck KGaANASDAQ:CXSP
11/12/200521:00PR Newswire (US)ChemGenex Reports Compelling Phase 2 Data Published In Leading Leukemia JournalNASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
07/11/200523:47PR Newswire (US)ChemGenex to Present at Rodman & Renshaw Techvest 7th Annual Healthcare ConferenceNASDAQ:CXSP
09/10/200515:00PR Newswire (US)Scientists Pinpoint Inflammation GeneNASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
26/09/200522:35PR Newswire (US)ChemGenex Personalized Medicine Clinical Trial Expanded to Patients with Breast and Ovarian CancersNASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
30/08/200513:14PR Newswire (US)2004-05 Financial Report Highlights Successful Year for ChemGenexNASDAQ:CXSP
04/08/200510:12PR Newswire (US)ChemGenex Joins New NASDAQ Health Care IndexNASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
27/06/200521:00PR Newswire (US)ChemGenex and Stragen Pharma Create Alliance to Accelerate Clinical Development and Commercialization of Ceflatonin(R)NASDAQ:CXSP
27/06/200514:57PR Newswire (US)ChemGenex to List On Nasdaq (Nasdaq SC: CXSP)NASDAQ:CXSP
 Apresentando as notícias mais relevantes sobre:NASDAQ:CXSP

Seu Histórico Recente

NYSE
PBR
Petroleo Brasileiro ADR
BOV
IBOV
Índice Bovespa
BOV
BBDC4
BRADESCO PN
BOV
ELET6
ELETROBRAS PNB
COIN
BRAZBTC
Brazio
COIN
LTCUSD
Litecoin
BOV
PETR3
PETROBRAS ON
NYSE
GGB
Gerdau
COIN
PLUS1BTC
PlusOneCoin
DBI
DAX
DAX
EU
PX1
CAC 40
BOV
ITSA4
ITAUSA PN
BOV
ELET3
ELETROBRAS ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados